Document is current

Article History

Received: 26 January 2024

Revised: 29 April 2024

Accepted: 2 May 2024

First Online: 8 July 2024

Einhaltung ethischer Richtlinien

:

: J. Wachtlin macht folgende Angaben: Consulting fees: Alcon, Bayer, Roche, Novartis, Appelis. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Alcon, Roche, Novartis, Appelis, Bayer. Payment for expert testimony: Bayer, Appelis, Roche. Participation on a Data Safety Monitoring Board or Advisory Board: Bayer. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Deutsche Retinologische Gesellschaft, BBAG, BVA, KV Berlin, ÄK Berlin, DOG, Makulakommision. H. Kaymak macht folgende Angaben: All support for the present manuscript (e.g., funding, provision of study materials, medical writing, article processing charges, etc.): Bayer Vital GmbH. medical writing, compensation for conducting the study. Grants or contracts from any entity: Novartis Pharma GmbH, Research funding made to Internationale Innovative Ophtalmochirurgie. Consulting fees: Hoya Holdings, Oculus Optikgeräte, Apellis, Consulting fees made to Internationale Innovative Ophthalmochirurgie. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Hoya Holdings, Roche Pharma AG, Bayer Vital GmbH, Rodenstock, Johnson & Johnson, Topcon, Lumithera, VSY Biotechnology, Honoraria for lectures made to Internationale Innovative Ophthalmochirurgie. Support for attending meetings and/or travel: Hoya Holdings, Johnson & Johnson, Bayer Vital, VSY Biotechnology, Roche Pharma AG, Financial support for attending and travel to congresses made to Internationale Innovative Ophthalmochirurgie. Participation on a Data Safety Monitoring Board or Advisory Board: Roche Pharma AG, Ora Clinical, Hoya Holdings, Honorarium for participation in Advisory Boards made to Internationale Innovative Ophthalmochirurgie. Receipt of equipment, materials, drugs, medical writing, gifts or other services: Topcon, Receipt of equipment for scientific purposes. H. Hoerauf macht folgende Angaben: Grants or contracts from any entity: Bayer, Novartis, Roche, Abbvie. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Bayer, Novartis, Roche, Abbvie, Biogen, Thea Pharma, Alcon. Participation on a Data Safety Monitoring Board or Advisory Board: Bayer, Alcon, Roche, Stadapharm, Abbvie. Stock or stock options: Bayer, Roche, Novartis. H. Allmeier is an employee of Bayer CC AG. He was the overall responsible for the conduct of the Auriga study. T. Machewitz is a full-time employee of Bayer Vital GmbH and he declares stock or stock options from Bayer. P. Scholz is a full-time employee of Bayer Vital GmbH. M. Schürks is a full-time employee of Bayer Vital GmbH and he declares stock or stock options from Bayer AG. N. Feltgen macht folgende Angaben: Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Speaker. Support for attending meetings and/or travel: Meetings and travel support (speaker). Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Deutsche Retinologische Gesellschaft, Deutsche Ophtalmologische Gesellschaft, Makulakommission.

: Die Daten dieses Beitrags basieren auf einer nicht-interventionellen Beobachtungsstudie an Menschen bei der klinische Daten aus der Behandlungsroutine dokumentiert wurden. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.